Goldman Sachs Starts Precision BioSciences Inc. (DTIL) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Jefferies Starts Precision BioSciences Inc. (DTIL) at Buy
April 22, 2019 6:42 AM EDTJefferies analyst Maury Raycroft initiates coverage on Precision BioSciences Inc. (NASDAQ: DTIL) with a Buy rating and a price target of $25.00.
For an analyst ratings summary and ratings history on Precision BioSciences Inc.... More
JPMorgan Starts Precision BioSciences Inc. (DTIL) at Overweight
April 22, 2019 1:41 AM EDTJPMorgan analyst Eric Joseph initiates coverage on Precision BioSciences Inc. (NASDAQ: DTIL) with a Overweight rating and a price target of $23.00.
Favors the company's competitive positioning in the manufacture of off-the0-shelf CAR Ts which is likely the next... MoreBarclays Starts Precision BioSciences Inc. (DTIL) at Overweight
April 22, 2019 12:45 AM EDTBarclays analyst Gena Wang initiates coverage on Precision BioSciences Inc. (NASDAQ: DTIL) with a Overweight rating and a price target of $24.00.
Believes the company's proprietary ARCUS genome-editing platform possesses unique advantages with editing efficiency largely comparable to other gene editing... More